Blog
RSS FeedPosted by Michael Wonder on 11 Aug 2020
Proposal for new calcineurin inhibitor listings on the Pharmaceutical Schedule
11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on ...
Posted by Michael Wonder on 10 Aug 2020
Coronavirus: cancer patient's urgent plea for treatment in New Zealand
10 August 2020 - A Christchurch cancer patient is missing out on potentially life-saving treatment due to rising COVID-19 cases ...
Posted by Michael Wonder on 04 Aug 2020
Trikafta manufacturer to fast track application to have 'miracle' cystic fibrosis drug funded in New Zealand
4 August 2020 - The miracle drug Trikafta is a step closer for New Zealanders living with cystic fibrosis, after ...
Posted by Michael Wonder on 04 Aug 2020
PHARMAC considering a new way of contracting for medicines
4 August 2020 - Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone ...
Posted by Michael Wonder on 02 Aug 2020
Access for Aotearoa - campaigning for access to modern medications for Kiwis with cystic fibrosis
3 August 2020 - It took eight years for New Zealanders living with CF to access the first of four ...
Posted by Michael Wonder on 01 Aug 2020
New Zealand Pharmaceutical Schedule - 1 August 2020
1 August 2020 - The August 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Jul 2020
Lockdown in Melbourne prevents Invercargill woman from receiving cancer treatment
30 July 2020 - Melbourne’s lockdown is preventing an Invercargill woman from travelling there for cancer treatment. ...
Posted by Michael Wonder on 30 Jul 2020
PHARMAC removes dispensing restrictions' - now distributing three months' supply
30 July 2020 - The majority of the temporary dispensing restrictions placed upon Government-funded medicine will be removed on Saturday. ...
Posted by Michael Wonder on 30 Jul 2020
Proposal to fund an additional brand of budesonide with eformoterol
30 July 2020 - PHARMAC is seeking feedback on a proposal to fund an additional brand (DuoResp Spiromax) of two ...
Posted by Michael Wonder on 29 Jul 2020
Paracetamol: supply issue
28 July 2020 - API Consumer Brands has advised PHARMAC that they continue to have a supply issue for Pharmacare paracetamol ...
Posted by Michael Wonder on 28 Jul 2020
PHARMAC report: should rich people get subsidised medicine?
29 July 2020 - Should wealthy New Zealanders have access to subsidised medicines when they could be investing in better ...
Posted by Michael Wonder on 26 Jul 2020
Mother of teen with cystic fibrosis pleads for PHARMAC to fund new medication
26 July 2020 - Seventeen-year-old Rotorua teenager Osiris Daniels has been living in isolation his entire life, a necessary requirement ...
Posted by Michael Wonder on 22 Jul 2020
Epilepsy medicine linked to deaths not same as previous funded drug — advocacy group
22 July 2020 - Testing commissioned by Patient Voice Aotearoa, a patient advocacy group, shows the three medicines given in New ...
Posted by Michael Wonder on 21 Jul 2020
COVID-19: PHARMAC warns pandemic could disrupt supply of paracetamol, other medicines
21 July 2020 - PHARMAC warns the COVID-19 pandemic could disrupt not only the supply of paracetamol, but other medications ...
Posted by Michael Wonder on 21 Jul 2020
PHARMAC, COVID-19 health response get slice of $302 million fund
21 July 2020 - Minister of Health Chris Hipkins has announced a financial boost for public health services, setting aside more ...